Medindia

X

Myrbetriq Receives FDA Approval

by Kathy Jones on  June 29, 2012 at 10:55 PM Drug News   - G J E 4
The US Food and Drug Administration has confirmed that it has approved Japanese drug maker Astellas Pharma's Myrbetriq pill for treating overactive bladder in adults.
 Myrbetriq Receives FDA Approval
Myrbetriq Receives FDA Approval
Advertisement

The approval was along the expected lines after an advisory committee voted that the drug's benefits in treating overactive bladder outweighed the risk of side effects which includes heart and liver problems. The decision came following results of clinical trials which showed that 50-milligram dose of the drug reduced the number of trips to the bathroom by four times over a period of 7 days when compared to placebo.

Advertisement
Stating that overactive bladder was an uncomfortable and potentially serious condition, Dr Victoria Kusiak, deputy director in an FDA office for drug evaluation, said, "An estimated 33 million Americans suffer from overactive bladder, which is uncomfortable, disrupting, and potentially serious. Today's approval provides a new treatment option for patients with this debilitating condition."



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All